Levonadifloxacin arginine salt

N/A

Report date: 2026/03/04 20:01:44
NMEQIDP

Base Information

Drug NameLevonadifloxacin arginine salt
Drug Alias Name左那氟沙星(S)-nadifloxacin arginine saltEmrokWCK-771WCK-771A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitorsTopoisomerase IV inhibitors
TargetsTopoisomerase IVBacterial DNA gyrase
Therapy Area/IndicationsAcute bacterial skin and skin structure infectionsAmino Acid Metabolism, Inborn ErrorsAnemia, Sickle Cell +[6] 
Global Approved IndicationsGram-Positive Bacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2019/12/13
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesWockhardt Bio Ag
China Registration ClassN/A

Develop Information

Active CompaniesWockhardt Ltd
Inactive CompaniesOffice Of Rare DiseasesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentNational Heart, Lung, And Blood Institute (Nhlbi)
Active IndicationsGram-Positive Bacterial Infections
Inactive IndicationsAcute bacterial skin and skin structure infectionsAmino Acid Metabolism, Inborn ErrorsAnemia, Sickle Cell +[5] 

Other Information

ATC CodeN/A
Related LinksN/A